ArticleScientific reports2026
Curcumin delivery system based on biodegradable polyhydroxybuterate Chitosan copolymer and Cobalt oxide nanoparticles against colorectal cancer.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In this study, a biodegradable nanocomposite composed of polyhydroxybutyrate-co-chitosan and cobalt oxide (PHB-co-CS/Co3O4) was developed for targeted and sustained in-vitro release of curcumin (CUR). The nanocomposite was prepared by varying the concentrations of Co3O4 nanoparticles (NPs) and using chitosan with different molecular weights (LCS, HCS) to optimize the release profile. The PHB-co-CS copolymer was synthesized through a coupling reaction between PHB-diol and the terminal isocyanate groups of chitosan, using stannous octanoate as a catalyst. PHB-diol was obtained via transesterification of PHB with ethylene glycol. Amine group in CS was protected by phthalic anhydrides followed by reaction with hexamethylene diisocyanato. Co3O4 NPs were synthesized by reacting cobalt acetate with sodium carbonate in ethylene glycol. CUR was first loaded onto the Co3O4 NPs and then dispersed within the PHB-co-CS copolymer matrix. Structural and chemical characterization was performed using X-ray diffraction (XRD) and Fourier transform infrared (FTIR) spectroscopy. In-vitro release studies were conducted in buffer solutions at pH 5.4 and 7.4, showing enhanced release in acidic conditions, which supports tumor-specific targeting. Formulations with lower molecular weight chitosan released curcumin more rapidly. Among the tested systems, the PHB-co-LCS/10%CUR@Co3O4 nanocomposite exhibited the strongest anticancer effect, with IC50 of 29.1 µg/mL against HCT-116 colorectal cancer cells. These results highlight the promise of combining green materials and sustainable approaches to develop effective, targeted drug delivery platforms for cancer treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.